Hartch Christa, Dietrich Mary S, Lancaster B Jeanette, Mulvaney Shelagh A, Stolldorf Deonni P
School of Nursing and Health Sciences, Manhattanville University, Purchase, NY, United States.
School of Nursing, Vanderbilt University, Nashville, TN, United States.
JMIR Hum Factors. 2025 Jan 7;12:e63653. doi: 10.2196/63653.
Research supports the use of mobile phone apps to promote medication adherence, but the use of and satisfaction with these apps among medically underserved patients with chronic illnesses remain unclear.
This study reports on the overall use of and satisfaction with a medication adherence app (Medisafe) in a medically underserved population.
Medically underserved adults who received care for one or more chronic illnesses at a federally qualified health center (FQHC) were randomized to an intervention group in a larger randomized controlled trial and used the app for 1 month (n=30), after which they completed a web-based survey. Objective data on app usage were provided as secondary data by the app company.
The participants were very satisfied with the app, with all participants (30/30, 100%) somewhat or strongly agreeing that they would recommend the app to family and friends. Participants strongly agreed (28/30, 93%) that the reminders helped them remember to take their medications at the correct time each day, and they (28/30, 93%) found the app easy to use. Additional features accessed by some included educational features and the adherence report. Participants noted the helpfulness of having a medication list on their phones, and some used it during medication reconciliation at doctor visits. Use of the Medfriend feature, which alerts a social support person if a medication is missed, was low (n=2), but those who used it were very positive about the feature.
A commercially available medication adherence app was found to be useful by participants, and they were satisfied with the app and the additional features provided. The use of medication adherence mobile phone apps has the potential to positively influence chronic disease management in a medically underserved population on a large scale.
ClinicalTrials.gov NCT05098743; https://clinicaltrials.gov/study/NCT05098743.
研究支持使用手机应用程序来促进药物依从性，但在医疗服务不足的慢性病患者中，这些应用程序的使用情况和满意度仍不明确。
本研究报告了在医疗服务不足人群中，一款药物依从性应用程序（Medisafe）的总体使用情况和满意度。
在一家联邦合格健康中心（FQHC）接受一种或多种慢性病治疗的医疗服务不足的成年人，在一项更大规模的随机对照试验中被随机分配到干预组，并使用该应用程序1个月（n = 30），之后他们完成了一项基于网络的调查。应用程序公司提供了关于应用程序使用情况的客观数据作为次要数据。
参与者对该应用程序非常满意，所有参与者（30/30，100%）或多或少或强烈同意他们会向家人和朋友推荐该应用程序。参与者强烈同意（28/30，93%）提醒功能帮助他们记住每天在正确的时间服药，并且他们（28/30，93%）发现该应用程序易于使用。一些参与者使用的其他功能包括教育功能和依从性报告。参与者指出在手机上有药物清单很有帮助，一些人在看医生进行药物核对时会使用它。Medfriend功能（如果错过服药会提醒社会支持人员）的使用频率较低（n = 2），但使用该功能的人对其评价很高。
参与者发现一款市售的药物依从性应用程序很有用，他们对该应用程序及其提供的附加功能感到满意。使用药物依从性手机应用程序有可能对医疗服务不足人群的慢性病管理产生积极的大规模影响。
ClinicalTrials.gov NCT05098743；https://clinicaltrials.gov/study/NCT05098743 。
